Special Focus Session

SF 20c - Unraveling the brain: can molecular imaging and theranostics transform neuropsychiatric and oncologic care?

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Valentina Garibotto, Geneva / CH

2
Molecular imaging of brain disconnectivity

Molecular imaging of brain disconnectivity

25:00Igor Yakushev, Munich / DE

3
Towards theranostics in neuro-oncology

Towards theranostics in neuro-oncology

25:00Nelleke Tolboom, Amsterdam / NL

4
PET imaging in the era of Alzheimer's disease modifying drugs

PET imaging in the era of Alzheimer's disease modifying drugs

25:00Valentina Garibotto, Geneva / CH

5
Panel discussion: How do we translate methodological advances into clinical practice?

Panel discussion: How do we translate methodological advances into clinical practice?

10:00Panel discussion: How do we translate methodological advances into clinical practice?

This session explores how molecular imaging and theranostic strategies redefine diagnosis and treatment across brain disorders, from neuropsychiatric conditions to oncologic care. Experts will present advances in mapping brain connectivity disruptions, targeted radioligand therapies for brain tumours, and PET-guided disease-modifying therapies in neurodegenerative disorders. Attendees will gain insights into translating these applications into clinical practice to improve patient outcomes.
5 min
Chairperson's introduction
Valentina Garibotto, Geneva / Switzerland
25 min
Molecular imaging of brain disconnectivity
Igor Yakushev, Munich / Germany
25 min
Towards theranostics in neuro-oncology
Nelleke Tolboom, Amsterdam / Netherlands
25 min
PET imaging in the era of Alzheimer's disease modifying drugs
Valentina Garibotto, Geneva / Switzerland
10 min
Panel discussion: How do we translate methodological advances into clinical practice?

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.